Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Indaptus Therapeutics, Inc.
Market Cap
$275.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$275.66M
Operating Margin
-2222.45%
TTM Avg
-1882.54%
3Y Avg
-1096.29%
5Y Avg
-863.53%
Market Cap
$278.45M
Operating Margin
-14.55%
TTM Avg
-6.56%
3Y Avg
-30.72%
5Y Avg
-57.13%
Market Cap
$283.44M
Operating Margin
0.00%
TTM Avg
-13.69%
3Y Avg
-1436.87%
5Y Avg
-1163.68%
Market Cap
$267.45M
Operating Margin
-775.98%
TTM Avg
-556.52%
3Y Avg
-379.20%
5Y Avg
-295.79%
Market Cap
$265.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$286.40M
Operating Margin
-1536.91%
TTM Avg
-768.46%
3Y Avg
-1621.10%
5Y Avg
-1715.52%
Market Cap
$264.72M
Operating Margin
-59.23%
TTM Avg
-35.16%
3Y Avg
-14.58%
5Y Avg
-11.13%
Market Cap
$262.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1307.00%
5Y Avg
-871.33%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | $275.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | -2222.45% | -1882.54% | -1096.29% | -863.53% |
| Aurora Cannabis Inc. (ACB)vs › | $278.45M | -14.55% | -6.56% | -30.72% | -57.13% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.44M | 0.00% | -13.69% | -1436.87% | -1163.68% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.45M | -775.98% | -556.52% | -379.20% | -295.79% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $265.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | -1536.91% | -768.46% | -1621.10% | -1715.52% |
| OraSure Technologies, Inc. (OSUR)vs › | $264.72M | -59.23% | -35.16% | -14.58% | -11.13% |
| Palisade Bio, Inc. (PALI)vs › | $262.97M | 0.00% | 0.00% | -1307.00% | -871.33% |
| AC Immune S.A. (ACIU)vs › | $262.07M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-30 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-30 | 0.00% |
